Effects of Pomegranate Seed Oil Supplementation in Patients With Advanced Dementia

The goal of this clinical study is to learn if Pomegranate Seed Oil supplementation works to combat urinary tract infections, recurrenturinary tract infections, or pneumonia and contributes to the tapering or discontinuation of antipsychotics in palliative care patients withadvanced dementia. The main questions it aims to answer are: * Does Pomegranate Seed Oil supplementation reduce the likelihood of developing a urinary tract infection? * Does Pomegranate Seed Oil supplementation prevent UTI reinfection? * Does Pomegranate Seed Oil supplementation reduce the likelihood of pneumonia? * Does Pomegranate Seed Oil supplementation contribute to the tapering or discontinuation of antipsychotics? Researchers will compare Pomegranate Seed Oil to care-as-usual to see if Pomegranate Seed Oil supplementation can increase quality of care in palliative care patients with advanced dementia.

NCT Number	NCT07432763
Lead Sponsor	Panhellenic Federation of Alzheimer's Disease and Related Disorders Collaborators: Greek Association of Alzheimer's Disease and Related Disorders (Alzheimer Hellas), RODI HELLAS SA
Conditions	Urinary Tract Infections (UTIs), Urinary Tract Infection, Recurrent, Antipsychotics Discontinuation, Antipsychotics Tapering
Enrollment	18 participants
Start Date	2024-05-01
Primary Completion	2024-10-31 (estimated)
Study Completion	2024-10-31 (estimated)
Updated on ClinicalTrials.gov	2026-02-25